Strategic Position

Biosceptre has three aspects to the Strategic positioning:

Biosceptre believes that it holds a significant advantage in these areas that together protect the business and its commercial value. In order to operate in Biosceptre’s business space, a rival pharmaceutical company will have to negotiate a license agreement to utilise the target, acquire knowledge about the receptor and antibody interactions and then initiate a development project.

Biosceptre intends to develop its therapeutic programmes to the point of having strong Phase II data prior to seeking appropriate deals to take products to market.